AgMedica Bioscience Inc. has announced that Health Canada issued an amended licence to them to permit sales of dried medicinal cannabis products from its Riverview Cultivation Facility in Chatham Ontario.
Company officials say this is another critical milestone in the growth of AgMedica.
“The expedited nature of the sales amendment comes 12 months after construction started and just six months after being granted their cultivation licence at the Riverview Facility,” company officials said in a media release.
“These significant achievements accelerate the timeline to revenue generation and are a direct result of the dedication and efforts of the entire team. The management team would like to thank all employees, partners, and shareholders for their efforts and continued support. AgMedica has received significant interest in its product offerings and will be launching its sales portal in the coming weeks.”
AgMedica Bioscience Inc. is a leader in the research and development of innovative cannabis-derived products to support the health and wellness journey of our clients.
Their investment in research and development is focused on scientific innovation that will have a positive impact on the health and wellness journey of our clients.
The company’s Riverview Cultivation Facility is located in Chatham, Ontario.
Phase I of our first innovative multi-tier cultivation facility is currently in production with a total annual capacity of 6,000kg of medical-grade cannabis.
Construction on Phase II of the Riverview Cultivation Facility is well under way and will bring total annual capacity up to 26,500 kg.
